Page last updated: 2024-10-28

miltefosine and Inflammatory Bowel Diseases

miltefosine has been researched along with Inflammatory Bowel Diseases in 1 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research Excerpts

ExcerptRelevanceReference
"Miltefosine inhibits T-cell proliferation and effectively reduces inflammation in the T-cell transfer model."7.79Miltefosine suppresses inflammation in a mouse model of inflammatory bowel disease. ( Duijvestein, M; Hommes, DW; Meijer, SL; Peppelenbosch, MP; te Velde, AA; van den Brink, GR; Verhaar, AP; Vos, AC; Wildenberg, ME, 2013)
"Miltefosine inhibits T-cell proliferation and effectively reduces inflammation in the T-cell transfer model."3.79Miltefosine suppresses inflammation in a mouse model of inflammatory bowel disease. ( Duijvestein, M; Hommes, DW; Meijer, SL; Peppelenbosch, MP; te Velde, AA; van den Brink, GR; Verhaar, AP; Vos, AC; Wildenberg, ME, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verhaar, AP1
Wildenberg, ME1
te Velde, AA1
Meijer, SL1
Vos, AC1
Duijvestein, M1
Peppelenbosch, MP1
Hommes, DW1
van den Brink, GR1

Other Studies

1 other study available for miltefosine and Inflammatory Bowel Diseases

ArticleYear
Miltefosine suppresses inflammation in a mouse model of inflammatory bowel disease.
    Inflammatory bowel diseases, 2013, Volume: 19, Issue:9

    Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cytokines; Disease Models, Animal; Humans; Immun

2013